The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

A proof-of-concept trial shows novel sarcoidosis PET/CT tracer detects inflammatory activity, supporting further clinical ...

Insmed is rated a hold, reflecting a robust therapeutic pipeline but persistent unprofitability, and is priced at a high premium to book value. Learn more about INSM stock here.

The Lung Institute provides comprehensive diagnostics and treatments to patients with illnesses that affect the lungs and breathing, including lung cancer, chronic obstructive pulmonary disease, ...

The pulmonary valve is located between the right ventricle and the pulmonary artery. The valve acts as a doorway that lets blood into and out of the heart. Pulmonary valve stenosis is when the ...

PEOPLE. IT’S THE SIMPLE THINGS. FOR LEAH WALKER HOLDING HER BABIES IN HER ARMS, MAKING THEM BOTTLES, MOMENTS SHE DOESN’T TAKE FOR GRANTED, MOMENTS SHE ALMOST DIDN’T GET TO HAVE. WHEN I GET TO HAVE ...

What Is Pulmonary Vascular Disease? The definition of pulmonary vascular disease is simple: any condition that affects the blood vessels along the route between the heart and lungs. Blood travels from ...

Crown Princess Mette-Marit of Norway is expected to undergo a lung transplant as testing indicated a "clear worsening" of her ...

The FDA today approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of progressive pulmonary fibrosis (PPF ...